Table 2.
Correlation between dimethylarginines and inflammatory markers
| 6 h | 12 h | 24 h | 3 d | 7 d | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| R | P | R | P | R | P | R | P | R | P | |
| ADMA vs. IL-6 | 0.059 | 0.659 | −0.024 | 0.860 | 0.001 | 0.997 | 0.272 | 0.039 | 0.344 | 0.008 |
| ADMA vs. CRP | −0.192 | 0.149 | 0.113 | 0.397 | 0.031 | 0.819 | 0.291 | 0.027 | 0.338 | 0.010 |
| ADMA vs. S100B | −0.106 | 0.430 | −0.073 | 0.585 | 0.144 | 0.279 | 0.082 | 0.540 | 0.214 | 0.106 |
| ADMA vs. MMP-9 | −0.104 | 0.440 | −0.153 | 0.254 | 0.131 | 0.330 | 0.031 | 0.818 | 0.039 | 0.775 |
| ADMA vs. TIMP-1 | 0.346 | 0.010 | 0.083 | 0.545 | 0.401 | 0.002 | 0.431 | 0.001 | 0.352 | 0.008 |
| ADMA vs. MCP-1 | 0.179 | 0.179 | −0.026 | 0.844 | 0.012 | 0.930 | 0.213 | 0.108 | 0.209 | 0.116 |
| SDMA vs. IL-6 | 0.237 | 0.073 | 0.219 | 0.099 | 0.139 | 0.297 | 0.389 | 0.003 | 0.405 | 0.002 |
| SDMA vs. CRP | −0.144 | 0.281 | 0.017 | 0.899 | −0.023 | 0.863 | 0.207 | 0.119 | 0.197 | 0.138 |
| SDMA vs. S100B | −0.110 | 0.410 | 0.033 | 0.808 | 0.135 | 0.313 | 0.036 | 0.788 | 0.182 | 0.170 |
| SDMA vs. MMP-9 | −0.062 | 0.649 | −0.115 | 0.393 | −0.132 | 0.329 | −0.015 | 0.913 | 0.055 | 0.684 |
| SDMA vs. TIMP-1 | 0.237 | 0.082 | −0.015 | 0.914 | 0.048 | 0.726 | 0.170 | 0.215 | 0.271 | 0.046 |
| SDMA vs. MCP-1 | 0.379 | 0.003 | 0.149 | 0.264 | 0.110 | 0.411 | 0.286 | 0.030 | 0.345 | 0.008 |
P <0.05 is considered statistically significant. ADMA, asymmetric dimethylarginine; CRP, C-reactive protein; IL-6, interleukin-6; MCP-1, monocyte chemotactic protein-1; MMP-9, matrix metalloproteinase-9; SDMA, symmetric dimethylarginine; TIMP-1, tissue inhibitor of matrix metalloproteinase-1.